Detalles de la búsqueda
1.
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
J Thromb Thrombolysis
; 56(3): 447-453, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37430158
Resultados
1 -
1
de 1
1
Próxima >
>>